OTCPK:TECR

Stock Analysis Report

Executive Summary

TechCare Corp., a technology company, engages in the design, development, and commercialization of a platform utilizing proprietary vaporization technology to enable health, wellness, and beauty treatments in the Netherlands and Israel.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Share Price & News

How has TechCare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TECR's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

8.7%

TECR

1.8%

US Medical Equipment

0.5%

US Market


1 Year Return

-70.8%

TECR

23.3%

US Medical Equipment

16.1%

US Market

Return vs Industry: TECR underperformed the US Medical Equipment industry which returned 23.3% over the past year.

Return vs Market: TECR underperformed the US Market which returned 16.1% over the past year.


Shareholder returns

TECRIndustryMarket
7 Day8.7%1.8%0.5%
30 Day-45.2%4.3%3.9%
90 Day-69.6%2.8%6.6%
1 Year-70.8%-70.8%24.3%23.3%18.7%16.1%
3 Year-91.4%-91.4%88.6%82.9%47.2%37.7%
5 Yearn/a116.3%92.9%61.5%43.7%

Price Volatility Vs. Market

How volatile is TechCare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is TechCare undervalued compared to its fair value and its price relative to the market?

2.98x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate TECR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate TECR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: TECR is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: TECR is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TECR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TECR is good value based on its PB Ratio (3x) compared to the US Medical Equipment industry average (3.8x).


Next Steps

Future Growth

How is TechCare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TechCare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of TECR’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access TechCare's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has TechCare performed over the past 5 years?

-15.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TECR has high quality earnings.

Growing Profit Margin: TECR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TECR is unprofitable, and losses have increased over the past 5 years at a rate of -15.4% per year.

Accelerating Growth: Unable to compare TECR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TECR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.3%).


Return on Equity

High ROE: TECR has a negative Return on Equity (-536.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is TechCare's financial position?


Financial Position Analysis

Short Term Liabilities: TECR's short term assets ($493.7K) exceeds its short term liabilities ($276.3K)

Long Term Liabilities: TECR's short term assets ($493.7K) exceeds its long term liabilities (87.6K)


Debt to Equity History and Analysis

Debt Level: TECR's debt to equity ratio (19.2%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if TECR's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: TECR has a high level of physical assets or inventory.

Debt Coverage by Assets: TECR's debt is covered by short term assets (assets are 6.2x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TECR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: TECR has less than a year of cash runway if free cash flow continues to reduce at historical rates of -23.6% each year


Next Steps

Dividend

What is TechCare's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate TECR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate TECR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TECR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TECR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TECR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of TechCare's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Zvi Yemini (68yo)

0.7yrs

Tenure

US$140,537

Compensation

Mr. Zvika Yemini, also known as Zvi, is Co-Owner of YMY Ltd. Mr. Yemini has been the Chairman of TechCare Corp. since August 17, 2016 and has been its Chief Executive Officer since March 1, 2019. Mr. Yemin ...


CEO Compensation Analysis

Compensation vs Market: Zvi's total compensation ($USD140.54K) is below average for companies of similar size in the US market ($USD504.52K).

Compensation vs Earnings: Zvi's compensation has been consistent with company performance over the past year.


Management Age and Tenure

2.3yrs

Average Tenure

Experienced Management: TECR's management team is considered experienced (2.3 years average tenure).


Board Age and Tenure

2.5yrs

Average Tenure

67yo

Average Age

Experienced Board: TECR's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$100,00030 Apr 19
Traistman Radziejewski Fundacja Ltd.
EntityCompany
Shares546,448
Max PriceUS$0.18
BuyUS$25,00030 Apr 19
Microdel Ltd.
EntityCompany
Shares136,612
Max PriceUS$0.18

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.4%.


Management Team

  • Zvi Yemini (68yo)

    Chairman & CEO

    • Tenure: 0.7yrs
    • Compensation: US$140.54k
  • Laurence Alexander

    European Chief Executive Officer

    • Tenure: 2.3yrs
  • Michel Bergh

    Chief Commercial Officer

    • Tenure: 2.3yrs
  • Tabe Ydo

    Chief Marketing Officer

    • Tenure: 2.3yrs

Board Members

  • Zvi Yemini (68yo)

    Chairman & CEO

    • Tenure: 0.7yrs
    • Compensation: US$140.54k
  • Oren Traistman (49yo)

    Independent Director

    • Tenure: 3.1yrs
    • Compensation: US$33.41k
  • Yossef De-Levy (67yo)

    Independent Director

    • Tenure: 3.1yrs
    • Compensation: US$32.46k
  • Nava Ravid

    Member of Advisory Board

    • Tenure: 2.5yrs
  • Michael Samish

    Member of Advisory Board

    • Tenure: 2.5yrs
  • Uri Stoin

    Member of Advisory Board

    • Tenure: 2.5yrs
  • George Pehlivanian

    Member of Advisory Board

    • Tenure: 2.5yrs

Company Information

TechCare Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: TechCare Corp.
  • Ticker: TECR
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$1.241m
  • Shares outstanding: 35.45m
  • Website: https://www.techcareltd.com

Number of Employees


Location

  • TechCare Corp.
  • 23 Hamelacha Street
  • Park Afek
  • Rosh HaAyin
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TECROTCPK (Pink Sheets LLC)YesNew Common StockUSUSDAug 2016
1PR1BST (Boerse-Stuttgart)YesNew Common StockDEEURAug 2016

Biography

TechCare Corp., a technology company, engages in the design, development, and commercialization of a platform utilizing proprietary vaporization technology to enable health, wellness, and beauty treatments ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/21 00:37
End of Day Share Price2019/11/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.